Function of Glycosomes in the Metabolism of Trypanosomatid Parasites and the Promise of Glycosomal Proteins as Drug Targets

Trypanosomatid Diseases: Molecular Routes to Drug Discovery

Volumn , Issue , 2013, Pages 121-151

  Gualdrón López, Melisa ^a   Michels, Paul A M ^a   Quiñones, Wilfredo ^b   Cáceres, Ana J ^b   Avilán, Luisana ^b   Concepción, Juan Luis ^b  

^a DE DUVE INSTITUTE   (Belgium)

^b FACULTAD DE CIENCIAS   (Venezuela)

Author keywords

Drug targets; Enzyme inhibitor; Glycosome; Life cycle; Peroxin; Trypanosomatid parasite

Indexed keywords

EID: 84886476739     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527670383.ch7     Document Type: Chapter

References (140)

1. Opperdoes, F.R. and Borst, P. (1977) Localization of nine glycolytic enzymes in a microbody-like organelle in Trypanosoma brucei: the glycosome. FEBS Lett., 80, 360-364.
2. Gualdrón-López, M., Brennand, A., Hannaert, V., Quiñones,W., Cáceres, A.J., Bringaud, F., Concepción, J.L., and Michels, P.A.M. (2012) When, how and why glycolysis became compartmentalised in the Kinetoplastea. A new look at an ancient organelle. Int. J. Parasitol., 42, 1-20.
3. Opperdoes, F.R. and Szikora, J.P. (2006) In silico prediction of the glycosomal enzymes of Leishmania major and trypanosomes. Mol. Biochem. Parasitol., 147, 193-206.
4. Helfert, S., Estévez, A.M., Bakker, B., Michels, P., and Clayton, C. (2001) Roles of triosephosphate isomerase and aerobic metabolism in Trypanosoma brucei. Biochem. J., 357, 117-125.
5. Verlinde, C.L.M.J., Hannaert, V., Blonski, C., Willson, M., Périé, J.J., Fothergill-Gilmore, L.A., Opperdoes, F.R. et al. (2001) Glycolysis as a target for the design of new anti-trypanosome drugs. Drug Resist. Updat., 4, 50-65.
6. Opperdoes, F.R. and Michels, P.A.M. (2001) Enzymes of carbohydrate metabolism as potential drug targets. Int. J. Parasitol., 31, 482-490.
7. Seyfang, A. and Duszenko, M. (1991) Specificity of glucose transport in Trypanosoma brucei. Effective inhibition by phloretin and cytochalasin B. Eur. J. Biochem., 202, 191-196.
8. Albert, M.A., Haanstra, J.R., Hannaert, V., Van Roy, J., Opperdoes, F.R., Bakker, B. M., and Michels, P.A.M. (2005) Experimental and in silico analyses of glycolytic flux control in bloodstream form Trypanosoma brucei. J. Biol. Chem., 280, 28306-28315.
9. Cáceres, A.J., Michels, P.A.M., and Hannaert, V. (2010) Genetic validation of aldolase and glyceraldehyde-3-phosphate dehydrogenase as drug targets in Trypanosoma brucei. Mol. Biochem. Parasitol., 169, 50-54.
10. Bakker, B.M.,Walsh, M.C., Ter Kuile, B.H., Mensonides, F.I., Michels, P.A.M., Opperdoes, F.R., and Westerhoff, H.V. (1999) Contribution of glucose transport to the control of the glycolytic flux in Trypanosoma brucei. Proc. Natl. Acad. Sci. USA, 96, 10098-10103.
11. Wiemer, E.A.C., Michels, P.A.M., and Opperdoes, F.R. (1995) The inhibition of pyruvate transport across the plasma membrane of the bloodstream form of Trypanosoma brucei and its metabolic implications. Biochem. J., 312, 479-484.
12. Bakker, B.M., Michels, P.A.M., Opperdoes, F.R., and Westerhoff, H.V. (1997) Glycolysis in bloodstream form Trypanosoma brucei can be understood in terms of the kinetics of the glycolytic enzymes. J. Biol. Chem., 272, 3207-3215.
13. Bakker, B.M., Michels, P.A.M., Opperdoes, F.R., and Westerhoff, H.V. (1999) What controls glycolysis in bloodstream form Trypanosoma brucei? J. Biol.Chem., 274, 14551-14559.
14. Bakker, B.M.,Westerhoff, H.V., Opperdoes, F.R., and Michels, P.A.M. (2000) Metabolic control analysis of glycolysis in trypanosomes as an approach to improve selectivity and effectiveness of drugs. Mol. Biochem. Parasitol., 106, 1-10.
15. Haanstra, J.R., Kerkhoven, E.J., Van Tuijl, A., Blits, M., Wurst, M., Van Nuland, R., Albert, M.A. et al. (2011) A domino effect in drug action: from metabolic assault towards parasite differentiation. Mol. Microbiol., 79, 94-108.
16. Schuster, R. and Holzhütter, H.G. (1995) Use of mathematical models for predicting the metabolic effect of largescale enzyme activity alterations. Application to enzyme deficiencies of red blood cells. Eur. J. Biochem., 229, 403-418.
17. Hornberg, J.J., Bruggeman, F.J., Bakker, B.M., and Westerhoff, H.V. (2007) Metabolic control analysis to identify optimal drug targets. Prog. Drug. Res., 64, 172-189.
18. Misset, O., Bos, O.J.M., and Opperdoes, F.R. (1986) Glycolytic enzymes of Trypanosoma brucei. Simultaneous purification intraglycosomal concentrations and physical properties. Eur. J. Biochem., 157, 441-453.
19. Cordeiro, A.T., Thiemann, O.H., and Michels, P.A.M. (2009) Inhibition of Trypanosoma brucei glucose-6-phosphate dehydrogenase by human steroids and their effects on the viability of cultured parasites. Bioorg. Med. Chem., 17, 2483-2489.
20. Gupta, S., Cordeiro, A.T., and Michels, P. A.M. (2011) Glucose-6-phosphate dehydrogenase is the target for the trypanocidal action of human steroids. Mol. Biochem. Parasitol., 176, 112-115.
21. Hanau, S., Rinaldi, E., Dallocchio, F., Gilbert, I.H., Dardonville, C., Adams, M.J., Gover, S., and Barrett, M.P. (2004) 6-Phosphogluconate dehydrogenase: a target for drugs in African trypanosomes. Curr. Med. Chem., 11, 2639-2650.
22. Gupta, S., Igoillo-Esteve, M., Michels, P. A.M., and Cordeiro, A.T. (2011) Glucose-6-phosphate dehydrogenase of trypanosomatids: characterization target validation and drug discovery. Mol. Biol. Int., 2011, 135701.
23. Roper, J.R., Güther, M.L.S., Milne, K.G., and Ferguson, M.A.J. (2002) Galactose metabolism is essential for the African sleeping sickness parasite Trypanosoma brucei. Proc. Natl. Acad. Sci. USA, 99, 5884-5889.
24. Roper, J.R., Güther, M.L.S., MacRae, J.I., Prescott, A.R., Hallyburton, I., Acosta-Serrano, A., and Ferguson, M.A.J. (2005) The suppression of galactose metabolism in procylic form Trypanosoma brucei causes cessation of cell growth and alters procyclin glycoprotein structure and copy number. J. Biol. Chem., 280, 19728-19736.
25. Turnock, D.C., Izquierdo, L., and Ferguson, M.A. (2007) The de novo synthesis of GDP-fucose is essential for flagellar adhesion and cell growth in Trypanosoma brucei. J. Biol. Chem., 282, 28853-28863.
26. Stokes, M.J., Güther, M.L.S., Turnock, D.C., Prescott, A.R., Martin, K.L., Alphey, M.S., and Ferguson, M.A.J. (2008) The synthesis of UDP-N-acetylglucosamine is essential for bloodstream form Trypanosoma brucei in vitro and in vivo and UDP-N-acetylglucosamine starvation reveals a hierarchy in parasite protein glycosylation. J. Biol. Chem., 283, 16147-16161.
27. Mariño, K., Güther, M.L., Wernimont, A.K., Amani, M., Hui, R., and Ferguson, M.A. (2010) Identification subcellular localization biochemical properties and high-resolution crystal structure of Trypanosoma brucei UDP-glucose pyrophosphorylase. Glycobiology, 20, 1619-1630.
28. Mariño, K., Güther, M.L., Wernimont, A.K., Qiu, W., Hui, R., and Ferguson, M.A. (2011) Characterization localization essentiality and high-resolution crystal structure of glucosamine-6-phosphate N-acetyltransferase from Trypanosoma brucei. Eukaryot. Cell, 10, 985-997.
29. Denton, H., Fyffe, S., and Smith, T.K. (2010) GDP-mannose pyrophosphorylase is essential in the bloodstream form of Trypanosoma brucei. Biochem. J., 425, 603-614.
30. Stoppani, A.O., Docampo, R., de Boiso, J. F., and Frasch, A.C. (1980) Effect of inhibitors of electron transport and oxidative phosphorylation on Trypanosoma cruzi respiration and growth. Mol. Biochem. Parasitol., 2, 3-21.
31. Cannata, J.J. and Cazzulo, J.J. (1984) The aerobic fermentation of glucose by Trypanosoma cruzi. Comp. Biochem. Physiol. B, 79, 297-308.
32. Sanchez-Moreno, M., Fernandez-Becerra, M.C., Castilla-Calvente, J.J., and Osuna, A. (1995) Metabolic studies by 1H NMR of different forms of Trypanosoma cruzi as obtained by 'in vitro' culture. FEMS Microbiol. Lett., 133, 119-125.
33. Taylor, M.B. and Gutteridge, W.E. (1987) Trypanosoma cruzi: subcellular distribution of glycolytic and some related enzymes of epimastigotes. Exp. Parasitol., 63, 84-97.
34. Besteiro, S., Biran, M., Biteau, N., Coustou, V., Baltz, T., Canioni, P., and Bringaud, F. (2002) Succinate secreted by Trypanosoma brucei is produced by a novel and unique glycosomal enzyme NADHdependent fumarate reductase. J. Biol. Chem., 277, 38001-38012.
35. Acosta, H., Dubourdieu, M., Quiñones, W., Cáceres, A., Bringaud, F., and Concepción, J.L. (2004) Pyruvate phosphate dikinase and pyrophosphate metabolism in the glycosome of Trypanosoma cruzi epimastigotes. Comp. Biochem. Physiol. B Biochem. Mol. Biol., 138, 347-356.
36. Concepción, J.L., Acosta, H., Quiñones, W., and Dubourdieu, M. (2001) An a-glycerophosphate dehydrogenase is present in Trypanosoma cruzi glycosomes. Mem. Inst. Oswaldo Cruz, 96, 697-701.
37. Sarkar, M., Hamilton, C.J., and Fairlamb, A.H. (2003) Properties of phosphoenolpyruvate mutase the first enzyme in the aminoethylphosphonate biosynthetic pathway in Trypanosoma cruzi. J. Biol. Chem., 278, 22703-22708.
38. Kollien, A.H. and Schaub, G.A. (2000) The development of Trypanosoma cruzi in Triatominae. Parasitol. Today, 16, 381-387.
39. Maugeri, D.A., Cannata, J.J., and Cazzulo, J.J. (2011) Glucose metabolism in Trypanosoma cruzi. Essays Biochem., 51, 15-30.
40. Engel, J.C., Franke de Cazzulo, B.M., Stoppani, A.O.M., Cannata, J.J.B., and Cazzulo, J.J. (1987) Aerobic glucose fermentation by Trypanosoma cruzi axenic culture amastigote-like forms during growth and differentiation to epimastigotes. Mol. Biochem. Parasitol., 26, 1-10.
41. Atwood, J.A., Weatherly, D.B., Minning, T.A., Bundy, B., Cavola, C., Opperdoes, F.R., Orlando, R., and Tarleton, R.L. (2005) The Trypanosoma cruzi proteome. Science, 309, 473-476.
42. Silber, A.M., Tonelli, R.R., Lopes, C.G., Cunha-e-Silva, N., Torrecilhas, A.C., Schumacher, R.I., Colli, W., and Alves, M.J. (2009) Glucose uptake in the mammalian stages of Trypanosoma cruzi. Mol. Biochem. Parasitol., 168, 102-108.
43. Berriman, M., Ghedin, E., Hertz-Fowler, C., Blandin, G., Renauld, H., Bartholomeu, D.C., Lennard, N.J. et al. (2005) The genome of the African trypanosome Trypanosoma brucei. Science, 309, 416-422.
44. Maugeri, D.A. and Cazzulo, J.J. (2004) The pentose phosphate pathway in Trypanosoma cruzi. FEMS Microbiol. Lett., 234, 117-123.
45. Urbina, J.A., Concepcion, J.L., Rangel, S., Visbal, G., and Lira, R. (2002) Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana. Mol. Biochem. Parasitol., 125, 35-45.
46. Allen, T.E. and Ullman, B. (1994) Molecular characterization and overexpression of the hypoxanthineguanine phosphoribosyltransferase gene from Trypanosoma cruzi. Mol. Biochem. Parasitol., 65, 233-245.
47. Urbina, J.A. and Docampo, R. (2003) Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol., 19, 495-501.
48. Urbina, J.A. (2010) Specific chemotherapy of Chagas disease: relevance current limitations and new approaches. Acta Trop., 115, 55-68.
49. Quiñones,W., Urbina, J.A., Dubourdieu, M., and Concepción, J.L. (2004) The glycosome membrane of Trypanosoma cruzi epimastigotes: protein and lipid composition. Exp. Parasitol., 106, 135-149.
50. Aboushadi, N., Engfelt, W.H., Paton, V.G., and Krisans, S.K. (1999) Role of peroxisomes in isoprenoid biosynthesis. J. Histochem. Cytochem., 47, 1127-1132.
51. Cáceres, A.J., Portillo, R., Acosta, H., Rosales, D., Quiñones,W., Avilan, L., Salazar, L. et al. (2003) Molecular and biochemical characterization of hexokinase from Trypanosoma cruzi. Mol. Biochem. Parasitol., 126, 251-262.
52. Cáceres, A.J., Quiñones,W., Gualdrón, M., Cordeiro, A., Avilán, L., Michels, P.A. M., and Concepción, J.L. (2007) Molecular and biochemical characterization of novel glucokinases from Trypanosoma cruzi and Leishmania spp. Mol. Biochem. Parasitol., 156, 235-245.
53. Cordeiro, A.T., Cáceres, A.J., Vertommen, D., Concepción, J.L., Michels, P.A.M., and Versées, W. (2007) The crystal structure of Trypanosoma cruzi glucokinase reveals features determining oligomerization and anomer specificity of hexosephosphorylating enzymes. J. Mol. Biol., 372, 1215-1226.
54. Murray, H.W., Berman, J.D., Davies, C.R., and Saravia, N.G. (2005) Advances in leishmaniasis. Lancet, 366, 1561-1577.
55. Naderer, T. and McConville, M.J. (2011) Intracellular growth and pathogenesis of Leishmania parasites. Essays Biochem., 51, 81-95.
56. McConville, M.J. and Naderer, T. (2011) Metabolic pathways required for the intracellular survival of Leishmania. Annu. Rev. Microbiol., 65, 543-561.
57. Coombs, G.H., Tetley, L., Moss, V.A., and Vickerman, K. (1986) Three dimensional structure of the Leishmania amastigote as revealed by computer-aided reconstruction from serial sections. Parasitology, 92, 13-23.
58. Coombs, G.H., Craft, J.A., and Hart, D.T. (1982) A comparative study of Leishmania mexicana amastigotes and promastigotes. Enzyme activities and subcellular locations. Mol. Biochem. Parasitol., 5, 199-211.
59. Mottram, J.C. and Coombs, G.H. (1985) Leishmania mexicana: subcellular distribution of enzymes in amastigotes and promastigotes. Exp. Parasitol., 59, 265-274.
60. Pabón, M.A., Cáceres, A.J., Gualdrón, M., Quiñones,W., Avilán, L., and Concepción, J.L. (2007) Purification and characterization of hexokinase from Leishmania mexicana. Parasitol. Res., 100, 803-810.
61. Rosenzweig, D., Smith, D., Opperdoes, F., Stern, S., Olafson, R.W., and Zilberstein, D. (2008) Retooling Leishmania metabolism: from sand fly gut to human macrophage. FASEB J., 22, 590-602.
62. Naderer, T. and McConville, M.J. (2008) The Leishmania-macrophage interaction: a metabolic perspective. Cell Microbiol., 10, 301-308.
63. Burchmore, R.J., Rodriguez-Contreras, D., McBride, K., Merkel, P., Barrett, M.P., Modi, G., Sacks, D., and Landfear, S.M. (2003) Genetic characterization of glucose transporter function in Leishmania mexicana. Proc. Natl. Acad. Sci. USA, 100, 3901-3906.
64. Feng, X., Rodriguez-Contreras, D., Buffalo, C., Bouwer, H.G., Kruvand, E., Beverley, S.M., and Landfear, S.M. (2009) Amplification of an alternate transporter gene suppresses the avirulent phenotype of glucose transporter null mutants in Leishmania mexicana. Mol. Microbiol., 71, 369-381.
65. Brotherton, M.C., Racine, G., Foucher, A. L., Drummelsmith, J., Papadopoulou, B., and Ouellette, M. (2010) Analysis of stagespecific expression of basic proteins in Leishmania infantum. J. Proteome Res., 9, 3842-3853.
66. Naderer, T., Ellis, M.A., Sernee, M.F., De Souza, D.P., Curtis, J., Handman, E., and McConville, M.J. (2006) Virulence of Leishmania major in macrophages and mice requires the gluconeogenic enzyme fructose-1,6-bisphosphatase. Proc. Natl. Acad. Sci. USA, 103, 5502-5507.
67. Keegan, F.P. and Blum, J.J. (1992) Utilization of a carbohydrate reserve comprised primarily of mannose by Leishmania donovani. Mol. Biochem. Parasitol., 53, 193-200.
68. Ralton, J.E., Naderer, T., Piraino, H.L., Bashtannyk, T.A., Callaghan, J.M., and McConville, M.J. (2003) Evidence that intracellular b1-2 mannan is a virulence factor in Leishmania parasites. J. Biol. Chem., 278, 40757-40763.
69. Garami, A. and Ilg, T. (2001) Disruption of mannose activation in Leishmania mexicana: GDP-mannose pyrophosphorylase is required for virulence but not for viability. EMBO J., 20, 3657-3666.
70. Naderer, T., Wee, E., and McConville, M.J. (2008) Role of hexosamine biosynthesis in Leishmania growth and virulence. Mol. Microbiol., 69, 858-869.
71. Joshi, M.B., Rogers, M.E., Shakarian, A. M., Yamage, M., Al-Harthi, S.A., Bates, P. A., and Dwyer, D.M. (2005) Molecular characterization, expression, and in vivo analysis of LmexCht1. The chitinase of the human pathogen, Leishmania mexicana. J. Biol. Chem., 280, 3847-3861.
72. Naderer, T., Heng, J., and McConville, M. J. (2010) Evidence that intracellular stages of Leishmania major utilize amino sugars as a major carbon source. PLoS Pathog., 6, e1001245.
73. Hart, D.T. and Opperdoes, F.R. (1984) The occurrence of glycosomes (microbodies) in the promastigote stage of four major Leishmania species. Mol. Biochem. Parasitol., 13, 159-172.
74. Paape, D., Lippuner, C., Schmid, M., Ackermann, R., Barrios-Llerena, M.E., Zimny-Arndt, U., Brinkmann, V. et al. (2008) Transgenic fluorescent Leishmania mexicana allow direct analysis of the proteome of intracellular amastigotes. Mol. Cell Proteomics, 7, 1688-1701.
75. Peña-Diaz, J., Montalvetti, A., Flores, C.L., Constan, A., Hurtado-Guerrero, R., De Souza, W., Gancedo, C. et al. (2004) Mitochondrial localization of the mevalonate pathway enzyme 3-hydroxy-3-methyl-glutaryl-CoA reductase in the Trypanosomatidae. Mol. Biol. Cell, 15, 1356-1363.
76. Ginger, M.L., McFadden, G.I., and Michels, P.A.M. (2010) Rewiring and regulation of cross-compartmentalized metabolism in protists. Philos. Trans. R. Soc. Lond. B Biol. Sci., 365, 831-845.
77. Carrero-Lérida, J., Pérez-Moreno, G., Castillo-Acosta, V.M., Ruiz-Pérez, L.M., and González-Pacanowska, D. (2009) Intracellular location of the early steps of the isoprenoid biosynthetic pathway in the trypanosomatids Leishmania major and Trypanosoma brucei. Int. J. Parasitol., 39, 307-314.
78. Colotti, G. and Ilari, A. (2011) Polyamine metabolism in Leishmania: from arginine to trypanothione. Amino Acids, 40, 269-285.
79. Krauth-Siegel, L.R., Comini, M.A., and Schlecker, T. (2007) The trypanothione system. Subcell. Biochem., 44, 231-251.
80. Gaur, U., Roberts, S.C., Dalvi, R.P., Corraliza, I., Ullman, B., and Wilson, M. E. (2007) An effect of parasite-encoded arginase on the outcome of murine cutaneous leishmaniasis. J. Immunol., 179, 8446-8453.
81. Balaña-Fouce, R., Calvo-Alvarez, E., Alvarez-Velilla, R., Prada, C.F., Pérez-Pertejo, Y., and Reguera, R.M. (2012) Role of trypanosomatid's arginase in polyamine biosynthesis and pathogenesis. Mol. Biochem. Parasitol., 181, 85-93.
82. Das, P., Lahiri, A., Lahiri, A., and Chakravortty, D. (2010) Modulation of the arginase pathway in the context of microbial pathogenesis: a metabolic enzyme moonlighting as an immune modulator. PLoS Pathog., 6, e1000899.
83. Opperdoes, F.R. and Michels, P.A.M. (2008) The metabolic repertoire of Leishmania and implications for drug discovery, in Leishmania: After the Genome (eds P.J. Myler and N. Fasel), Caister Academic Press, Norwich, pp. 123-158.
84. Wilkinson, S.R., Prathalingam, S.R., Taylor, M.C., Horn, D., and Kelly, J.M. (2005) Vitamin C biosynthesis in trypanosomes: a role for the glycosome. Proc. Natl. Acad. Sci. USA, 102, 11645-11650.
85. Biyani, N. and Madhubala, R. (2011) Leishmania donovani encodes a functional enzyme involved in vitamin C biosynthesis: arabino-1,4-lactone oxidase. Mol. Biochem. Parasitol., 180, 76-85.
86. Hassan, H.F., Mottram, J.C., and Coombs, G.H. (1985) Subcellular localisation of purine-metabolising enzymes in Leishmania mexicana mexicana. Comp. Biochem. Physiol. B, 81, 1037-1040.
87. Zarella-Boitz, J.M., Rager, N., Jardim, A., and Ullman, B. (2004) Subcellular localization of adenine and xanthine phosphoribosyltransferases in Leishmania donovani. Mol. Biochem. Parasitol., 134, 43-51.
88. Boitz, J.M. and Ullman, B. (2006) A conditional mutant deficient in hypoxanthine-guanine phosphoribosyltransferase and xanthine phosphoribosyltransferase validates the purine salvage pathway of Leishmania donovani. J. Biol. Chem., 281, 16084-16089.
89. Carter, N.S., Yates, P.A., Gessford, S.K., Galagan, S.R., Landfear, S.M., and Ullman, B. (2010) Adaptive responses to purine starvation in Leishmania donovani. Mol. Microbiol., 78, 92-107.
90. French, J.B., Yates, P.A., Soysa, D.R., Boitz, J.M., Carter, N.S., Chang, B., Ullman, B., and Ealick, S.E. (2011) The Leishmania donovani UMP synthase is essential for promastigote viability and has an unusual tetrameric structure that exhibits substrate-controlled oligomerization. J. Biol. Chem., 286, 20930-20941.
91. Yernaux, C., Fransen, M., Brees, C., Lorenzen, S., and Michels, P.A.M. (2006) Trypanosoma brucei glycosomal ABC transporters: identification and membrane targeting. Mol. Membr. Biol., 23, 157-172.
92. Igoillo-Esteve, M., Mazet, M., Deumer, G., Wallemacq, P., and Michels, P.A.M. (2011) Glycosomal ABC transporters of Trypanosoma brucei: characterisation of their expression topology and substrate specificity. Int. J. Parasitol., 41, 429-438.
93. Visser, N., Opperdoes, F.R., and Borst, P. (1981) Subcellular compartmentation of glycolytic intermediates in Trypanosoma brucei. Eur. J. Biochem., 118, 521-526.
94. Hammond, D.J., Aman, R.A., and Wang, C.C. (1985) The role of compartmentation and glycerol kinase in the synthesis of ATP within the glycosome of Trypanosoma brucei. J. Biol. Chem., 260, 15646-15654.
95. Haanstra, J.R., Van Tuijl, A., Kessler, P., Reijnders,W., Michels, P.A.M., Westerhoff, H.V., Parsons, M., and Bakker, B.M. (2008) Compartmentation prevents a lethal turbo-explosion of glycolysis in trypanosomes. Proc. Natl. Acad. Sci. USA, 105, 17718-17723.
96. Bakker, B.M., Mensonides, F.I., Teusink, B., Van Hoek, P., Michels, P.A.M., and Westerhoff, H.V. (2000) Compartmentation protects trypanosomes from the dangerous design of glycolysis. Proc. Natl. Acad. Sci. USA, 97, 2087-2092.
97. Gualdrón-López, M., Vapola, M.H., Miinalainen, I.J., Hiltunen, J.K., Michels, P.A., and Antonenkov, V.D. (2012) Channel-forming activities in the glycosomal fraction from the bloodstream form of Trypanosoma brucei. PLoS ONE, 7, e34530.
98. Reumann, S. (2000) The structural properties of plant peroxisomes and their metabolic significance. Biol. Chem., 381, 639-648.
99. Antonenkov, V.D. and Hiltunen, J.K. (2012) Transfer of metabolites across the peroxisomal membrane. Biochim. Biophys. Acta, 1822, 1374-1386.
100. Moyersoen, J., Choe, J., Fan, E., Hol, W.G.J., and Michels, P.A.M. (2004) Biogenesis of peroxisomes and glycosomes: trypanosomatid glycosome assembly is a promising new drug target. FEMS Microbiol. Rev., 28, 603-643.
101. Galland, N. and Michels, P.A.M. (2010) Comparison of the peroxisomal matrix protein import system of different organisms. Exploration of possibilities for developing inhibitors of the import system of trypanosomatids for antiparasite chemotherapy. Eur. J. Cell Biol., 89, 621-637.
102. Rokka, A., Antonenkov, V.D., Soininen, R., Immonen, H.L., Pirilä, P.L., Bergmann, U., Sormunen, R.T. et al. (2009) Pxmp2 is a channel-forming protein in mammalian peroxisomal membrane. PLoS ONE, 4, e5090.
103. Duszenko, M., Ginger, M.L., Brennand, A., Gualdrón-López, M., Colombo, M.I., Coombs, G.H., Coppens, I. et al. (2011) Autophagy in protists. Autophagy, 7, 127-158.
104. Brennand, A., Gualdrón-López, M., Coppens, I., Rigden, D.J., Ginger, M.L., and Michels, P.A.M. (2011) Autophagy in parasitic protists: unique features and drug targets. Mol. Biochem. Parasitol., 177, 83-99.
105. Herman, M., Pérez-Morga, D., Schtickzelle, N., and Michels, P.A.M. (2008) Turnover of glycosomes during differentiation of Trypanosoma brucei. Autophagy, 4, 294-308.
106. Herman, M., Gillies, S., Michels, P.A.M., and Rigden, D.J. (2006) Autophagy and related processes in trypanosomatids: insight from genomic and bioinformatics analyses. Autophagy, 2, 107-118.
107. Eakin, A.E., Guerra, A., Focia, P.J., Torres-Martinez, J., and Craig, S.P. (1997) Hypoxanthine phosphoribosyltransferase from Trypanosoma cruzi as a target for structure-based inhibitor design: crystallization and inhibition studies with purine analogs. Antimicrob. Agents Chemother., 41, 1686-1692.
108. Monzani, P.S., Trapani, S., Thiemann, O. H., and Oliva, G. (2007) Crystal structure of Leishmania tarentolae hypoxanthineguanine phosphoribosyltransferase. BMC Struct. Biol., 7, 59.
109. Shaw, M.P., Bond, C.S., Roper, J.R., Gourley, D.G., Ferguson, M.A.J., and Hunter, W.N. (2003) High-resolution crystal structure of Trypanosoma brucei UDP-galactose 40-epimerase: a potential target for structure-based development of novel trypanocides. Mol. Biochem. Parasitol., 126, 173-180.
110. Willson, M., Callens, M., Kuntz, D.A., Périé, J., and Opperdoes, F.R. (1993) Synthesis and activity of inhibitors highly specific for the glycolytic enzymes from Trypanosoma brucei. Mol. Biochem. Parasitol., 59, 201-210.
111. Morgan, H.P., McNae, I.W., Nowicki, M. W., Zhong, W., Michels, P.A.M., Auld, D. S., Fothergill-Gilmore, L.A., and Walkinshaw, M.D. (2011) The trypanocidal drug suramin and other trypan blue mimetics are inhibitors of pyruvate kinases and bind to the adenosine site. J. Biol. Chem., 286, 31232-31240.
112. Nowicki, M.W., Tulloch, L.B., Worrall, L., McNae, I.W., Hannaert, V., Michels, P.A. M., Fothergill-Gilmore, L.A. et al. (2008) Design synthesis and trypanocidal activity of lead compounds based on inhibitors of parasite glycolysis. Bioorg. Med. Chem., 16, 5050-5061.
113. Dax, C., Duffieux, F., Chabot, N., Coincon, M., Sygush, J., Michels, P.A.M., and Blonski, C. (2006) Selective irreversible inhibition of fructose-1,6-bisphosphate aldolase from Trypanosoma brucei. J. Med. Chem., 49, 1499-1502.
114. Azéma, L., Lherbet, C., Baudoin, C., and Blonski, C. (2006) Cell permeation of a Trypanosoma brucei aldolase inhibitor: evaluation of different enzyme-labile phosphate protecting groups. Bioorg. Med. Chem. Lett., 16, 3440-3444.
115. Aronov, A.M., Suresh, S., Buckner, F.S., Van Voorhis,W.C., Verlinde, C.L., Opperdoes, F.R., Hol,W.G.J., and Gelb, M.H. (1999) Structure-based design of submicromolar biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase. Proc. Natl. Acad. Sci. USA, 96, 4273-4278.
116. Bressi, J.C., Verlinde, C.L., Aronov, A.M., Shaw, M.L., Shin, S.S., Nguyen, L.N., Suresh, S. et al. (2001) Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design. J. Med. Chem., 44, 2080-2093.
117. Kennedy, K.J., Bressi, J.C., and Gelb, M.H. (2001) A disubstituted NAD analogue is a nanomolar inhibitor of trypanosomal glyceraldehyde-3-phosphate dehydrogenase. Bioorg. Med. Chem. Lett., 11, 95-98.
118. Bressi, J.C., Choe, J., Hough, M.T., Buckner, F.S., Van Voorhis, W.C., Verlinde, C.L., Hol,W.G.J., and Gelb, M. H. (2000) Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-N6-substituted adenosine. J. Med. Chem., 43, 4135-4150.
119. Sharlow, E.R., Lyda, T.A., Dodson, H.C., Mustata, G., Morris, M.T., Leimgruber, S.S., Lee, K.H. et al. (2010) A target-based high throughput screen yields Trypanosoma brucei hexokinase small molecule inhibitors with antiparasitic activity. PLoS Negl. Trop. Dis., 4, e659.
120. Chambers, J.W., Kearns, M.T., Morris, M.T., and Morris, J.C. (2008) Assembly of heterohexameric trypanosome hexokinases reveals that hexokinase 2 is a regulable enzyme. J. Biol. Chem., 283, 14963-14970.
121. Montalvetti, A., Bailey, B.N., Martin, M.B., Severin, G.W., Oldfield, E., and Docampo, R. (2001) Bisphosphonates are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase. J. Biol. Chem., 276, 33930-33937.
122. Hudock, M.P., Sanz-Rodríguez, C.E., Song, Y., Chan, J.M., Zhang, Y., Odeh, S., Kosztowski, T. et al. (2006) Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates. J. Med. Chem., 49, 215-223.
123. Sanz-Rodríguez, C.E., Concepción, J.L., Pekerar, S., Oldfield, E., and Urbina, J.A. (2007) Bisphosphonates as inhibitors of Trypanosoma cruzi hexokinase: kinetic and metabolic studies. J. Biol. Chem., 282, 12377-12387.
124. Orenes Lorente, S., Gómez, R., Jiménez, C., Cammerer, S., Yardley, V., de Luca-Fradley, K., Croft, S.L. et al. (2005) Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa. Bioorg. Med. Chem., 13, 3519-3529.
125. Sealey-Cardona, M., Cammerer, S., Jones, S., Ruiz-Pérez, L.M., Brun, R., Gilbert, I. H., Urbina, J.A., and González-Pacanowska, D. (2007) Kinetic characterization of squalene synthase from Trypanosoma cruzi: selective inhibition by quinuclidine derivatives. Antimicrob. Agents Chemother., 51, 2123-2129.
126. Urbina, J.A., Concepción, J.L., Caldera, A., Payares, G., Sanoja, C., Otomo, T., and Hiyoshi, H. (2004) In vitro and in vivo activities of E5700 and ER-119884, two novel orally active squalene synthase inhibitors against Trypanosoma cruzi. Antimicrob. Agents Chemother., 48, 2379-2387.
127. Urbina, J.A., Concepción, J.L., Montalvetti, A., Rodriguez, J.B., and Docampo, R. (2003) Mechanism of action of 4-phenoxyphenoxyethyl thiocyanate (WC-9) against Trypanosoma cruzi the causative agent of Chagas' disease. Antimicrob. Agents Chemother., 7, 2047-2050.
128. Wilkinson, S.R., Meyer, D.J., Taylor, M.C., Bromley, E.V., Miles, M.A., and Kelly, J.M. (2002) The Trypanosoma cruzi enzyme TcGPXI is a glycosomal peroxidase and can be linked to trypanothione reduction by glutathione or tryparedoxin. J. Biol. Chem., 277, 17062-17071.
129. Wilkinson, S.R. and Kelly, J.M. (2003) The role of glutathione peroxidases in trypanosomatids. Biol. Chem., 384, 517-525.
130. Gutierrez-Correa, J., Fairlamb, A.H., and Stoppani, A.O. (2001) Trypanosoma cruzi trypanothione reductase is inactivated by peroxidase-generated phenothiazine cationic radicals. Free Radic. Res., 34, 363-378.
131. Rivarola, H.W., Fernández, A.R., Enders, J.E., Fretes, R., Gea, S., Suligoy, M., Palma, J.A., and Paglini-Oliva, P. (1999) Thioridazine treatment modifies the evolution of Trypanosoma cruzi infection in mice. Ann. Trop. Med. Parasitol., 93, 695-702.
132. Lo Presti, M.S., Rivarola, H.W., Bustamante, J.M., Fernández, A.R., Enders, J.E., Fretes, R., Gea, S., and Paglini-Oliva, P.A. (2004) Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected mice. Int. J. Antimicrob. Agents, 23, 634-636.
133. Ruda, G.F.,Wong, P.E., Alibu, V.P., Norval, S., Read, K.D., Barrett, M.P., and Gilbert, I.H. (2010) Aryl phosphoramidates of 5-phospho erythronohydroxamic acid a new class of potent trypanocidal compounds. J. Med. Chem., 53, 6071-6078.
134. Marr, J.J. and Berens, R.L. (1983) Pyrazolopyrimidine metabolism in the pathogenic Trypanosomatidae. Mol. Biochem. Parasitol., 7, 339-356.
135. Ullman, B. and Carter, D. (1997) Molecular and biochemical studies on the hypoxanthine-guanine phosphoribosyltransferases of the pathogenic haemoflagellates. Int. J. Parasitol., 27, 203-213.
136. Koutinas, A.F., Saridomichelakis, M.N., Mylonakis, M.E., Leontides, L., Polizopoulou, Z., Billinis, C., Argyriadis, D. et al. (2001) A randomised blinded placebo-controlled clinical trial with allopurinol in canine leishmaniosis. Vet. Parasitol., 98, 247-261.
137. Torres, M., Bardagí, M., Roura, X., Zanna, G., Ravera, I., and Ferrer, L. (2011) Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol. Vet. J., 188, 346-351.
138. Gobbi, P., Lo Presti, M.S., Fernández, A. R., Enders, J.E., Fretes, R., Gea, S., Paglini-Oliva, P.A., and Rivarola, H.W. (2007) Allopurinol is effective to modify the evolution of Trypanosoma cruzi infection in mice. Parasitol. Res., 101, 1459-1462.
139. Apt, W., Aguilera, X., Arribada, A., Pérez, C., Miranda, C., Sánchez, G., Zulantay, I. et al. (1998) Treatment of chronic Chagas' disease with itraconazole and allopurinol. Am. J. Trop. Med. Hyg., 59, 133-138.
140. Freymann, D.M., Wenck, M.A., Engel, J.C., Feng, J., Focia, P.J., Eakin, A.E., and Craig, S.P. (2000) Efficient identification of inhibitors targeting the closed active site conformation of the HPRT from Trypanosoma cruzi. Chem. Biol., 7, 957-968.